2 unchanged sentences
our IPO, our Common Stock was quoted on Nasdaq under the symbol “IZTC.” When we changed our corporate name on February 10,
−Removed: 2025, to eXoZymes Inc., the trading symbol was changed.
−Removed: of March 12, 2025, we had approximately 757 shareholders of record of the Common Stock and we believe over 739 shareholders who hold
−Removed: their shares of Common Stock in street name.
+Added: 2025, to eXoZymes Inc., the trading symbol was changed to “EXOZ”.
+Added: of March 16, 2026, we had approximately 577 shareholders of record of the Common Stock and we believe there are additional shareholders that hold their shares in street name.
Distributions
2 unchanged sentences
will be determined by the management of eXoZymes, from time to time.
−Removed: Investors should not look to any distribution that we might
−Removed: make to be a regular income item in an investor’s portfolio.
−Removed: We anticipate that any income will be retained and used in our
−Removed: completed its initial public offering of shares of Common Stock on November 11, 2024, pursuant to the Registration Statement
−Removed: Each share of Common Stock was sold at a public offering price of $8.00, and the Company raised a gross amount of
−Removed: $15,901,328 and net proceeds of $15,206,543.
−Removed: the initial public offering on November 11, 2024, the Company has used approximately $5,149,980 of the net proceeds.
−Removed: Approximately
−Removed: (i) $4,243,022 was paid to MDB Capital Holdings LLC for related party loans that were used to support our operations in 2024, (ii)
−Removed: $143,615 was used to purchase additional lab equipment, which enhanced the labs operational capabilities, and (iii) $763,343 was disbursed for working capital.
+Added: Investors should not look to any distribution that we might make
+Added: to be a regular income item in an investor’s portfolio.
+Added: We anticipate that any income will be retained and used in our operations.
Authorized for Issuance Under Equity Compensation Plans
+Added: Plan category
of securities to be issued upon exercise of outstanding awards
2 unchanged sentences
of securities remaining available for future issuance under equity compensation plans
−Removed: Equity Incentive Award Plan, approved by security holders*
−Removed: award plans not approved by security holders
−Removed: The 2020 Equity Incentive Award Plan provides for awards for up to 2,489,467 shares of shares of Common Stock.
−Removed: As of December 31, 2024, there are a total of 317,022 shares of Common Stock available for issuance.
−Removed: As of December 31, 2024, of the 2,172,445 securities to be issued upon exercise and vesting of awards, 1,747,789 represent share options with a weighted
−Removed: average exercise price of $4.66 and 424,656 represent Restricted Stock Unit awards which do not require payment of an exercise
+Added: 2020 Equity Incentive Award Plan,
+Added: approved by security holders*
+Added: 2025 Equity Incentive Award Plan, approved
+Added: by security holders*
+Added: Equity award plans not
+Added: approved by security holders
+Added: The 2020 Equity Incentive Award Plan provides awards for up to 2,489,467 shares of shares of Common Stock.
+Added: As of December 31, 2025,
+Added: there are a total of 317,022 shares of Common Stock available for issuance.
+Added: As of December 31, 2025, of the 2,488,055 securities to be issued upon exercise and vesting of awards, 2,011,269 represent share options
+Added: with a weighted average exercise price of $5.67 and 436,786 represent Restricted Stock Unit awards which do not require payment of an
+Added: exercise price.
The Restricted Stock Unit awards are not included in the calculation of the weighted average exercise price above.
−Removed: Selected Financial Data
−Removed: are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, and therefore we are not required to provide the information
−Removed: under this item.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.